All of the attention lately has been on the allocations for 2017-2019, but funding related to the 2014-2016 allocations continues to be awarded at a steady pace. In December 2016, in a flurry of activity, the Global Fund Board approved funding in five different categories.

The Board authorized funding from the 2014-2016 allocations for both country and regional applicants that had not previously received funding from the allocations. The Board also approved additional funding from portfolio optimization (i.e. reinvestment of forecasted unspent funds across the Fund’s grant portfolio) for shortened grants and early applicants. In addition, the Board approved funding for initiatives on the Unfunded Quality Demand (UQD) register. Finally, the Board approved additional funding (“reinvestments”) from savings achieved in programs that have already been funded under the 2014-2016 allocations.

All of the awards were based on recommendations of the Grant Approvals Committee (GAC).

In this article, we provide an overview of these latest approvals.

Additional funding for country applicants

The Board approved $40.5 million for six grants from five components and countries. The biggest award went to Bolivia TB ($10.7 million), but probably the most significant award was the one to the State of Lagos in Nigeria. This is the first time the Fund has awarded funding to a state government in Nigeria. Funding states or provinces directly is one of the strategies the Fund said it will be further exploring to mitigate risk and increase impact in large countries with a federal structure of government. Lagos received $9.6 million which was reprogrammed from existing funds within the federal NGA-H-NACA grant for its HIV program.

See Table 1 for details on the funding awards to country applicants.

Table 1: Funding for country grants approved by the Global Fund, December 2016 ($ million)

Country (Component)	Grant Name	Grant End Date	Principal Recipient	Approved Funding
				Existing	New	Total
Algeria (HIV)	DZA-H-MOH	2019-12-31	Ministry of Health	0.0 m	6.5 m	6.5 m
Bolivia (TB)	BOL-T-UNDP	2019-12-31	UNDP	0.0 m	10.7 m	10.7 m1
El Salvador (HIV)	SLV-H-MOH	2018-12-31	Ministry of Health	3.8 m	1.3 m	5.1 m
	SLV-H-PLAN	2018-12-31	Plan International	2.2 m	4.8 m	7.0 m
Guyana (malaria)	GYA-M-MOH	2019-12-31	Ministry of Health	1.2 m	0.4 m	1.6 m
Nigeria (HIV)	NGA-H-LSMOH	2017-12-31	Lagos MOH	9.6 m	0.0 m	9.6 m2
TOTALS				16.8 m	23.7 m	40.5 m

See separate article in this issue for additional information on some of these country awards.

Additional funding for regional applicants

Four regional programs received $23.4 million. The biggest award went to the MOSASWA Cross-Border Initiative for a malaria grant ($9.8 million). See Table 2 for details on all four awards.

Table 2: Funding for regional grants approved by the Global Fund, December 2016 ($ million)

Applicant	Component	Grant Name	Grant End Date	Approved Funding
Alliance for Public Health Ukraine	TB/HIV	QMZ-C-APH	2019-12-31	3.9 m
Asian Pacific Network of People Living with HIV/AIDS (APN+)	HIV	QSA-H-APN+	(2020-03-31)	3.6 m1
Australian Federation of AIDS Organizations (AFAO)	HIV	QSE-H-AFAO	2018-12-31	2.3 m
ITPC-West Africa	HIV	QPR-H-ITPC	2019-12-31	3.8 m2
MOSASWA Cross-Border Initiative	Malaria	QPA-M-LSDI	2019-12-31	9.8 m3
TOTALS				23.4 m

See separate article in this issue for additional information on some of these regional awards.

Additional funding for shortened grants and early applicants

Two shortened and eight early applicant grants received additional funding in the amount of $138 million. The largest number of awards (six) went to Myanmar, an early applicant. The biggest awards also went to Myanmar grants – i.e. $26.3 million for a TB/HIV grant managed by UNOPS; $25.9 million for a TB/HIV grant managed by Save the Children; and $25.1 million for a malaria grant managed by UNOPS. See Table 3 for details on all of the awards in this category.

Table 3: Additional Funding for shortened grants and early applicants approved by the Global Fund, January 2017 ($ million)

Applicant (Component)	Grant Name	Principal Recipient	Additional  Approved Funding
EMMIE (malaria)	QMP-M-PSI	Population Services International	0.7 m
Iraq (TB)	IRQ-T-IOM	International Organization for Migration	3.0 m
Myanmar (malaria)	MYN-M-SCF	Save the Children	5.8 m
	MYN-M-UNOPS	UNOPS	25.1 m
Myanmar (TB/HIV)	MYN-H-SCF	Save the Children	25.8 m
	MYN-H-UNOPS	UNOPS	26.3 m
	MYN-T-SCF	Save the Children	5.5 m
	MYN-T-UNOPS	UNOPS	16.4 m
Regional Artemisinin Initiative (RAI) (Malaria)	QMU-M-UNOPS	UNOPS	15.5 m
Zimbabwe (malaria)	ZWE-M-MOHCC	Ministry of Health and Child Care	8.2 m
TOTAL			132.3 m

In all cases, the awards were designed to allow the components to provide services through to the end of 2017.

Funding for initiatives on UQD register

Seven unfunded quality demand initiatives from five countries were awarded $22 million in funding. See Table 4 for more details.

¹ Converted from euros at 1.0577.

² This refers to how much is left in the UQD register for each country after these awards.

³ With the $5.1 million in funding awarded, the UQD for Myanmar TB is reduced to zero. However, at the same time, new UQD for Myanmar TB/HIV as an early applicant receiving additional funding will be registered in the amount of $12.0 million.